Riskpilot← Back to searchSign inGet full accessBIOVOTEC AS
ASActiveOrg 913037790Haakon Viis Gate 5, 0161 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20141 employeeswww.biovotec.com
Revenue 2024
NOK 0
EBITDA margin
—
+25% vs 2023
Equity ratio
82.3%
Financial strength
Net profit 2024
NOK -11,4M
+31% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -12,9M | +25% |
| Net profit | NOK -11,4M | +31% |
| Total assets | NOK 13,9M | -47% |
| Equity | NOK 11,4M | -50% |
| Employees | 1 | — |
Legal name
BIOVOTEC AS
Org number
913037790
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
8. januar 2014
Share capital
NOK 1 235 573
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikling av produkter og tjenester relatert til eggeskallmembran og derivater derav, salg av produkter, utstyr og tjenester relatert til dette, konsulenttjenester samt og investeringer i verdipapirer relatert til dette området.
Address
Haakon Viis Gate 5, 0161 Oslo
Website
www.biovotec.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 872 | 2 006 | 9 026 | 1 448 | 0 |
| Staff expenses | −2 352 | −1 799 | −1 011 | −0 | −0 |
| EBITDA | −8 460 | −10 645 | −466 | −17 154 | −12 872 |
| Depreciation & amort. | −103 | −103 | −103 | −103 | −103 |
| EBIT | −8 563 | −10 748 | −569 | −17 258 | −12 976 |
| Net financials | 1 463 | −605 | 419 | 866 | 1 624 |
| Profit before tax | −7 100 | −11 353 | −150 | −16 392 | −11 352 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −7 100 | −11 353 | −150 | −16 392 | −11 352 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 42 220 | 34 465 | 20 565 | 26 068 | 13 903 |
| Equity | 30 450 | 19 097 | 18 947 | 22 789 | 11 437 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 770 | 15 368 | 1 618 | 3 279 | 2 467 |
| Total debt | 11 770 | 15 368 | 1 618 | 3 279 | 2 467 |
EBITDA margin
-1287228100.0%
This company
15.8%
Market median
-8147013391% vs market
20202024
Equity ratio
82.3%
This company
38.2%
Market median
+115% vs market
20202024
Return on equity
-99.3%
This company
18.4%
Market median
-640% vs market
20202024
Net profit margin
-1135160500.0%
This company
8.1%
Market median
-14014327260% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Former (3) | ||
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Chairman | 2023 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 15.85% | 15.85% | 2022 | |
| Individual | 14.41% | 14.41% | 2024 | |
| Company | 12.09% | 12.09% | 2024 | |
| Company | 9.18% | 9.18% | 2024 | |
| Company | 6.93% | 6.93% | 2024 | |
| Company | 5.98% | 5.98% | 2024 | |
| Company | 5.82% | 5.82% | 2024 | |
| Company | 5.67% | 5.67% | 2024 | |
| Company | 4.46% | 4.46% | 2024 | |
| Individual | 2.81% | 2.81% | 2024 | |
| Company | 2.51% | 2.51% | 2024 | |
| Company | 1.77% | 1.77% | 2024 | |
| Company | 1.64% | 1.64% | 2024 | |
| Individual | 1.32% | 1.32% | 2022 | |
| Company | 1.3% | 1.3% | 2024 | |
| Company | 1.28% | 1.28% | 2024 | |
| Company | 1.22% | 1.22% | 2024 | |
| Individual | 1.2% | 1.2% | 2024 | |
| Individual | 1.19% | 1.19% | 2024 | |
| Company | 1.07% | 1.07% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOVOTEC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Harald Magnus Sommer Andreassen | Board of Directors | 0 companies |
| Terje Birger Hannisdahl | Board of Directors | 0 companies |
| Allen Glen Mason | Board of Directors | 0 companies |
| Henri-Pierre Suso | Board of Directors | 0 companies |
| Trond Elling Gjelsten | Chairman | 0 companies |
| Ralf Schmidt | Chairman | 0 companies |